Amedisys Debt to Equity Ratio 2010-2023 | AMED
Current and historical debt to equity ratio values for Amedisys (AMED) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Amedisys debt/equity for the three months ending December 31, 2023 was 0.32.
| Amedisys Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2023-12-31 |
$0.94B |
$1.12B |
0.84 |
| 2023-09-30 |
$0.93B |
$1.09B |
0.85 |
| 2023-06-30 |
$0.92B |
$1.06B |
0.87 |
| 2023-03-31 |
$0.81B |
$1.13B |
0.72 |
| 2022-12-31 |
$0.87B |
$1.11B |
0.79 |
| 2022-09-30 |
$0.91B |
$1.07B |
0.85 |
| 2022-06-30 |
$0.96B |
$1.04B |
0.93 |
| 2022-03-31 |
$0.89B |
$1.02B |
0.87 |
| 2021-12-31 |
$0.88B |
$0.98B |
0.90 |
| 2021-09-30 |
$0.99B |
$0.95B |
1.04 |
| 2021-06-30 |
$0.72B |
$0.88B |
0.83 |
| 2021-03-31 |
$0.78B |
$0.79B |
0.99 |
| 2020-12-31 |
$0.76B |
$0.81B |
0.93 |
| 2020-09-30 |
$0.85B |
$0.76B |
1.12 |
| 2020-06-30 |
$0.92B |
$0.72B |
1.28 |
| 2020-03-31 |
$0.76B |
$0.68B |
1.12 |
| 2019-12-31 |
$0.62B |
$0.64B |
0.97 |
| 2019-09-30 |
$0.61B |
$0.60B |
1.01 |
| 2019-06-30 |
$0.64B |
$0.56B |
1.14 |
| 2019-03-31 |
$0.66B |
$0.52B |
1.27 |
| 2018-12-31 |
$0.23B |
$0.48B |
0.49 |
| 2018-09-30 |
$0.28B |
$0.45B |
0.63 |
| 2018-06-30 |
$0.34B |
$0.41B |
0.84 |
| 2018-03-31 |
$0.29B |
$0.55B |
0.53 |
| 2017-12-31 |
$0.30B |
$0.52B |
0.58 |
| 2017-09-30 |
$0.29B |
$0.51B |
0.56 |
| 2017-06-30 |
$0.31B |
$0.49B |
0.63 |
| 2017-03-31 |
$0.27B |
$0.48B |
0.57 |
| 2016-12-31 |
$0.27B |
$0.46B |
0.59 |
| 2016-09-30 |
$0.28B |
$0.45B |
0.62 |
| 2016-06-30 |
$0.28B |
$0.43B |
0.66 |
| 2016-03-31 |
$0.30B |
$0.41B |
0.72 |
| 2015-12-31 |
$0.27B |
$0.41B |
0.66 |
| 2015-09-30 |
$0.27B |
$0.39B |
0.69 |
| 2015-06-30 |
$0.27B |
$0.38B |
0.70 |
| 2015-03-31 |
$0.26B |
$0.37B |
0.70 |
| 2014-12-31 |
$0.27B |
$0.40B |
0.68 |
| 2014-09-30 |
$0.30B |
$0.38B |
0.78 |
| 2014-06-30 |
$0.34B |
$0.37B |
0.91 |
| 2014-03-31 |
$0.36B |
$0.36B |
1.00 |
| 2013-12-31 |
$0.35B |
$0.37B |
0.95 |
| 2013-09-30 |
$0.38B |
$0.38B |
1.00 |
| 2013-06-30 |
$0.24B |
$0.47B |
0.51 |
| 2013-03-31 |
$0.25B |
$0.46B |
0.54 |
| 2012-12-31 |
$0.28B |
$0.45B |
0.61 |
| 2012-09-30 |
$0.30B |
$0.57B |
0.53 |
| 2012-06-30 |
$0.32B |
$0.54B |
0.59 |
| 2012-03-31 |
$0.33B |
$0.53B |
0.61 |
| 2011-12-31 |
$0.34B |
$0.52B |
0.65 |
| 2011-09-30 |
$0.34B |
$0.51B |
0.65 |
| 2011-06-30 |
$0.41B |
$0.93B |
0.44 |
| 2011-03-31 |
$0.42B |
$0.90B |
0.47 |
| 2010-12-31 |
$0.42B |
$0.88B |
0.48 |
| 2010-09-30 |
$0.42B |
$0.85B |
0.49 |
| 2010-06-30 |
$0.44B |
$0.83B |
0.53 |
| 2010-03-31 |
$0.44B |
$0.78B |
0.56 |
| 2009-12-31 |
$0.44B |
$0.74B |
0.59 |
| 2009-09-30 |
$0.45B |
$0.69B |
0.65 |
| 2009-06-30 |
$0.44B |
$0.64B |
0.69 |
| 2009-03-31 |
$0.49B |
$0.60B |
0.82 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$2.978B |
$2.236B |
|
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
|
